Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer
Authors:
- Jacqueline I. BereskaJBJacqueline I. Bereska
- Inez M. VerpalenIVInez M. Verpalen
- for the Pancreatobiliary and Hepatic Artificial Intelligence Research (PHAIR) consortiumFCfor the Pancreatobiliary and Hepatic Artificial Intelligence Research (PHAIR) consortium
Open Access
- 12 February 2024
- journal article
- research article
- Published by Springer Nature in European Radiology Experimental
- Vol. 8 (1) , 1-10
Abstract
Objective: This study aimed to develop and evaluate an automatic model using artificial intelligence (AI) for quantifying vascular involvement and classifying tumor resectability stage in patients with pancreatic ductal adenocarcinoma (PDAC), primarily to support radiologists in referral centers. Resectability of PDAC is determined by the degree of vascular involvement on computed tomography scans (CTs), which is associated with considerable inter-observer variability. Methods: We developed a semisupervised machine learning segmentation model to segment the PDAC and surrounding vasculature using 613 CTs of 467 patients with pancreatic tumors and 50 control patients. After segmenting the relevant structures, our model quantifies vascular involvement by measuring the degree of the vessel wall that is in contact with the tumor using AI-segmented CTs. Based on these measurements, the model classifies the resectability stage using the Dutch Pancreatic Cancer Group criteria as either resectable, borderline resectable, or locally advanced (LA). Results: We evaluated the performance of the model using a test set containing 60 CTs from 60 patients, consisting of 20 resectable, 20 borderline resectable, and 20 locally advanced cases, by comparing the automated analysis obtained from the model to expert visual vascular involvement assessments. The model concurred with the radiologists on 227/300 (76%) vessels for determining vascular involvement. The model’s resectability classification agreed with the radiologists on 17/20 (85%) resectable, 16/20 (80%) for borderline resectable, and 15/20 (75%) for locally advanced cases. Conclusions: This study demonstrates that an AI model may allow automatic quantification of vascular involvement and classification of resectability for PDAC. Relevance statement: This AI model enables automated vascular involvement quantification and resectability classification for pancreatic cancer, aiding radiologists in treatment decisions, and potentially improving patient outcomes. Key points: • High inter-observer variability exists in determining vascular involvement and resectability for PDAC. • Artificial intelligence accurately quantifies vascular involvement and classifies resectability for PDAC. • Artificial intelligence can aid radiologists by automating vascular involvement and resectability assessments. GraphicalKeywords
Funding Information
- SURF (EINF-3539)
This publication has 17 references indexed in Scilit:
- Fully Automatic Deep Learning Framework for Pancreatic Ductal Adenocarcinoma Detection on Computed TomographyCancers, 2022
- CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot StudyRadiology, 2021
- Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialTrials, 2021
- Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trialBMC Cancer, 2021
- nnU-Net: a self-configuring method for deep learning-based biomedical image segmentationNature Methods, 2020
- Quantifying vascular invasion in pancreatic cancer—a contrast CT based method for surgical resectability evaluationPhysics in Medicine & Biology, 2020
- Current Approaches to Pancreatic Cancer ScreeningThe American Journal of Pathology, 2019
- Pathologic classification of “pancreatic cancers”: current concepts and challengesChinese Clinical Oncology, 2017
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2017
- 3D Slicer as an image computing platform for the Quantitative Imaging NetworkMagnetic Resonance Imaging, 2012